This inventor holds 5 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Innovations by Robert D. Mass
Introduction
Robert D. Mass is a notable inventor based in Mill Valley, CA (US). He has made significant contributions to the field of cancer therapy, holding a total of 5 patents. His work focuses on improving treatment methods for patients with tumors that overexpress specific genes.
Latest Patents
One of his latest patents is a gene detection assay aimed at enhancing the likelihood of an effective response to EGFR antagonist cancer therapy. This invention provides a method for more effective treatment of patients diagnosed with tumors overexpressing EGFR. The method involves administering a cancer-treating dose of the EGFR antagonist, preferably alongside chemotherapeutic agents, to patients whose tumor cells show amplification of the erbB1 gene. Another significant patent by Mass is a gene detection assay for improving the likelihood of an effective response to HER2 antibody cancer therapy. This invention similarly offers a method for treating patients with tumors overexpressing HER2, utilizing a HER2 antibody in conjunction with chemotherapeutic agents.
Career Highlights
Robert D. Mass is currently associated with Genentech, Inc., where he continues to innovate in the field of cancer treatment. His work has been instrumental in developing targeted therapies that improve patient outcomes.
Collaborations
He has collaborated with notable coworkers such as Gwendolyn Fyfe and Eric Holmgren, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Robert D. Mass is a distinguished inventor whose work in cancer therapy has led to significant advancements in treatment options for patients. His innovative patents reflect his commitment to improving healthcare outcomes through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile